Monthly Archives: July 2015

Replay Available of Webcast Featuring Biothera Pharmaceutical Technology

EAGAN, MN — July 21, 2015 — Biothera Pharmaceutical Senior Vice President of Research Jeremy Graff, Ph.D. explained new research during a webinar today that shows how Imprime PGG targets multiple cells types that orchestrate a coordinated anti-tumor response involving both the innate and adaptive immune system. The webinar was part of the Biopharma Dealmarkers series hosted by Nature.com. Click here to for a replay of the webinar. Biothera...

Read More


Biothera Pharmaceutical Inc. Announces Board of Directors

EAGAN, Minn. — July 7, 2015 — Biothera Holding Corp. today announced the election of the board of directors for Biothera Pharmaceutical Inc., a wholly owned subsidiary that is developing a clinical stage cancer immunotherapy drug. The 10 directors are Brent Ahrens, Dr. Alex Giaquinto, Mike Grey, Dr. Annalisa Jenkins, Steven Karel, Andrew LaFrence, Richard Mueller, Walter Ogier, Dr. Bruno Osterwalder and Dr. Dwight Porter....

Read More